Study: NCT04735445

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Digital rectal exam and / or anal cytology (day 1 and after 36 months)
Description: For anal screening in MSM man or woman with abnormal cervical cytology, genital warts or having anal sex (day 1 and after 36 months)

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Semestral digital rectal exam and / or anal cytology if abnormal → ANOSCOPY with biopsy
Description: For anal screening in MSM man or woman with abnormal cervical cytology, genital warts or having anal sex (semestral)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Cervical cytology and cervical sample for HPV detection (day 1 and after 36 months)
Description: For Cervix Screening in sexually active woman (day 1 and after 36 months)

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Semestral cervical cytology and cervical sample for HPV detection
Description: For Cervix Screening in sexually active woman (semestral)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Appointment for mammography (day 1 and after 36 months)
Description: For Breast Screening in woman between 50-70 years old (day 1 and after 36 months)

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Annual appointment for mammography
Description: For Breast Screening in woman between 45-70 years old (annual)

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Semestral appointment for liver ultrasound
Description: For Hepatic Screening:~Cirrhosis or Chronic HBV, and meet any of the following risk factors:~* Asian male\> 40 years old~* Asian woman\> 50 years old~* African man or woman~* HCC family history

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Semestral appointment for liver ultrasound
Description: Having chronic liver disease with fibrosis ≥ F3 or Presents chronic HBV

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Semestral blood collection for alpha-fetoprotein and others hepatic biomarkers determination
Description: Having chronic liver disease with fibrosis ≥ F3 or Presents chronic HBV

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Fecal occult blood test (day 1 and after 36 months)
Description: For Colon Screening:~Age between 50-70 years old

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Annual fecal occult blood test
Description: For Colon Screening:~Age older than 40 years

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Digital rectal exam and PSA determination (day 1 and after 36 months)
Description: For Prostate Screening:~Man older than 50 years

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Annual digital rectal exam and PSA determination
Description: For Prostate Screening:~Man older than 50 years

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Annual appointment for low dose computed tomography for lung screening
Description: For Lung Screening: should accomplish~ALL the following criteria:~* Age \> 40 years~* Active smoker or former smoker\<3 years, with IPY ≥20. IPY: index of packages-year: nº packages that smoke per day x nº years smoking~* No contraindications for thoracic surgery~* No lung infection in the last 2 months

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Annual general inspection for skin lesions suggestive of malignancy
Description: For Skin Screening:~Woman ≥18 years Man ≥40 years